PD-1阻害剤により制御困難な局所，あるいは領域病変に対する救済手術-Reference-Cited by-同舟云学术

PD-1阻害剤により制御困難な局所，あるいは領域病変に対する救済手術

Published:2023 Issue:2 Volume:33 Page:163-168
ISSN:1349-581X
Container-title:JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
language:en
Short-container-title:Toukeibu geka

Author:

Sato Fumihiko¹,Ono Takeharu¹,Sato Kiminobu¹,Kuroiwa Taikai¹,Kurita Takashi¹,Sueyoshi Shintaro¹,Chitose Shun-ichi¹,Umeno Hirohito¹

Affiliation:

1. Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine

Publisher

Japan Society for Head and Neck Surgery

Subject

Management of Technology and Innovation

Link

https://www.jstage.jst.go.jp/article/jjshns/33/2/33_33.163/_pdf

Reference20 articles.

1. 1） Zumsteg ZS, Luu M, Yoshida EJ, et al: Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base. Cancer 123：4583-4593, 2017.

2. 2）松尾美央子，西嶋利光，小池浩次：初診時遠隔転移を伴う頭頸部扁平上皮癌に対する化学放射線療法の有用性．頭頸部癌，43：488-492，2017．

3. 3）高橋克昌，西岡由樹，井田翔太，他：初診時に遠隔転移を伴う頭頸部扁平上皮癌に対する治療の妥当性．日耳鼻，121：1288-1293，2018．

4. 4） NCCN Clinical Practice Guideline in Oncology （NCCN Guidelines）: National Comprehensive Cancer Network; Head and Neck Cancers Version 1, 2023. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

5. 5） Yasumatsu R, Shimizu Y, Hanai N, et al: Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study. Int J Clin Oncol 27：95-104, 2022.